Pasteur Institute:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Pasteur Institute - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9299
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pasteur Institute is a non-profit foundation that provides research, health services and teaching services. The foundation conducts research in the areas of biology, genomes and genetics, immunology, infection and epidemiology, microbiology, neuroscience, parasitology and mycology, structural biology and chemistry, and virology, among others. It carries out discoveries for prevention, diagnosis and treatment of infectious diseases including ebola, malaria, AIDS, tuberculosis, Zika, neurodegenerative diseases, Alzheimer and Parkinson disease, cancers, autism, and others. Institut Pasteur also offers classes and workshops, predoctoral and doctoral courses, and online courses. The foundation partners with research institutes, private foundations, international organizations, universities academic organizations, associations, and bilateral and multilateral initiatives. Institut Pasteur is headquartered in Paris, France.

Pasteur Institute – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pasteur Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pasteur Institute, Medical Devices Deals, 2012 to YTD 2018 9
Pasteur Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Pasteur Institute, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
In-Cell-Art, BioNet-Asia and Pasteur Institute Enter into Partnership Agreement 11
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 12
Institut Pasteur Korea Enters into Drug Discovery Agreement with Pharos 13
Kainos Medicine Enters into Agreement with Institut Pasteur Korea 14
J2H Biotech Enters into Research Partnership with Institut Pasteur Korea 15
MRC Technology Enters into Co-Development Agreement with IPS-CAS 16
Institut Pasteur and Chan Soon-Shiong Institute Form Joint Venture 17
Institut Pasteur Korea Enters into Research Agreement with DNDi 18
Ferring Pharma Partners with Institut Pasteur 19
Moderna Therapeutics Enters into Research Agreement with Institut Pasteur 20
Institut Pasteur Korea and DNDi Enter into Research Agreement 21
Licensing Agreements 22
J2H Biotech Enters into Licensing Agreement with Institut Pasteur Korea 22
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 23
Pasteur Institute – Key Competitors 24
Pasteur Institute – Key Employees 25
Pasteur Institute – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Government and Public Interest 28
Jul 25, 2018: Benefits of early antiretroviral therapy in HIV-infected children 28
Product News 29
Jun 13, 2018: Yellow fever: a new method for testing vaccine safety 29
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Pasteur Institute, Pharmaceuticals & Healthcare, Key Facts 2
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pasteur Institute, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pasteur Institute, Deals By Therapy Area, 2012 to YTD 2018 8
Pasteur Institute, Medical Devices Deals, 2012 to YTD 2018 9
Pasteur Institute, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
In-Cell-Art, BioNet-Asia and Pasteur Institute Enter into Partnership Agreement 11
Chongqing Zhifei Biological Products Enters into Research Agreement with Institut Pasteur of Shanghai Chinese Academy of Sciences 12
Institut Pasteur Korea Enters into Drug Discovery Agreement with Pharos 13
Kainos Medicine Enters into Agreement with Institut Pasteur Korea 14
J2H Biotech Enters into Research Partnership with Institut Pasteur Korea 15
MRC Technology Enters into Co-Development Agreement with IPS-CAS 16
Institut Pasteur and Chan Soon-Shiong Institute Form Joint Venture 17
Institut Pasteur Korea Enters into Research Agreement with DNDi 18
Ferring Pharma Partners with Institut Pasteur 19
Moderna Therapeutics Enters into Research Agreement with Institut Pasteur 20
Institut Pasteur Korea and DNDi Enter into Research Agreement 21
J2H Biotech Enters into Licensing Agreement with Institut Pasteur Korea 22
ILiAD Biotech Enters Into Licensing Agreement With Inserm Transfert And Institut Pasteur De Lille For Bordetella Pertussis Vaccine Technology 23
Pasteur Institute, Key Competitors 24
Pasteur Institute, Key Employees 25
Pasteur Institute, Subsidiaries 26

List of Figures
Pasteur Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Pasteur Institute, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Pasteur Institute, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Pasteur Institute, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Pasteur Institute:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ebiquity plc (EBQ):企業の財務・戦略的SWOT分析
    Summary Ebiquity plc (Ebiquity) is a marketing and media consultancy service provider. The company’s services include marketing performance optimization services, media value measurement and market intelligence. Its business areas comprise data analytics and advanced analytics. Ebiquity’s data analy …
  • Northeastern Rural Electric Membership Corp:企業の戦略的SWOT分析
    Northeastern Rural Electric Membership Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors a …
  • Major Drilling Group International Inc (MDI):企業の財務・戦略的SWOT分析
    Major Drilling Group International Inc (MDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Alliant Credit Union:企業の戦略的SWOT分析
    Alliant Credit Union - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析
    Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Medicines for Malaria Venture:製薬・医療:M&Aディール及び事業提携情報
    Summary Medicines for Malaria Venture (MMV) is a drug developing company that discovers and delivers new, effective and affordable antimalarial drugs. The center provides products that offers efficacy against drug-resistant strains of plasmodium falciparum, potential for intermittent treatments, saf …
  • Anpario Plc (ANP):企業の財務・戦略的SWOT分析
    Summary Anpario Plc (Anpario), formerly Kiotech International Plc is a producer and distributor of natural feed additives for animal health, hygiene and nutrition. The company develops products for poultry, pig, ruminant and animal feed markets that include acidifiers, essential oils, enzymes, pelle …
  • H.I.S. Co., Ltd.:戦略・SWOT・企業財務分析
    H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary H.I.S. Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • AorTech International Plc (AOR):医療機器:M&Aディール及び事業提携情報
    Summary AorTech International plc (AorTech) is an Intellectual Property (IP) holding company. It develops and commercializes biologically stable polymers for next generation medical devices. It provides a broad range of polyurethane technologies for applications in cardiovascular surgery, interventi …
  • Foley Family Wines Limited:企業の戦略・SWOT・財務分析
    Foley Family Wines Limited - Strategy, SWOT and Corporate Finance Report Summary Foley Family Wines Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Laissez-Faire Catering Pty Ltd
    Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Laissez-Faire Catering Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Bonterra Energy Corp (BNE):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonterra Energy Corp (Bonterra) is an oil and gas company. It acquires and develops producing or undeveloped oil and gas properties. It produces crude oil, natural gas and natural gas liquids. The company principally operates in the provinces of Alberta, British Columbia and Saskatchewan in …
  • Emera (Caribbean) Inc.:企業の戦略的SWOT分析
    Emera (Caribbean) Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Troy Resources Limited:企業の戦略・SWOT・財務分析
    Troy Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Troy Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Insys Therapeutics Inc (INSY):企業の財務・戦略的SWOT分析
    Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Automatic Data Processing Inc (ADP):企業の財務・戦略的SWOT分析
    Automatic Data Processing Inc (ADP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Syneron Medical Ltd:企業の戦略的SWOT分析
    Syneron Medical Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Pacific Edge Ltd (PEB):企業の財務・戦略的SWOT分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that develops, discovers, and commercializes diagnostic tests for the early detection and monitoring of cancer. It offers lead products such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It also develops Cxco …
  • Extreme Networks, Inc. (EXTR):企業の財務・戦略的SWOT分析
    Extreme Networks, Inc. (EXTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Edwards Lifesciences Corp (EW)-製薬・医療分野:企業M&A・提携分析
    Summary Edwards Lifesciences Corp (Edwards) is a global medical technology company, which focuses on the development, manufacture and marketing of products and technologies used for the treatment of structural heart disease and critical conditions. It develops and commercializes heart valve products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆